Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5867 posts found.

computer_and_doctor

Standing together: Supercharging the clinical trial in Europe

September 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, biotech, clinical trials, drugs, pharma, pharmaceutical

The European Medicines Agency is on the cusp of rolling out one of the most ground-breaking digital platforms for facilitating …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 15, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cosentyx, Eli Lilly, Martin Skreli, Teva, pharma, top ten

This week has been a particularly eventful one for the industry: among our top stories, Martin Shkreli finally heads to …
News

Recipharm and Kancera collaborate to manufacture clinical trial supply

September 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm, a leading contract development and manufacturing organisation (CDMO) and Kancera, a development company focused on cancer therapy, have signed …
News
Press release
data

GDPR and Human Data Samples: Being ‘somewhat prepared’ is not enough

September 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GDPR, biotech, data, drugs, pharma, pharmaceutical

Thomas Hirse, Partner, and Paetrick Sakowski, Associate, CMS, discuss what pharmaceutical companies need to be aware of ahead of the …
Feature

Recipharm and CTC launch integrated first in human service

September 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm, biotech, drugs, pharma, pharmaceutical

Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch …
News
Press release

J&J backs out of $1.1 billion hep C deal, wiping 22.2% from Achillion’s stock

September 12, 2017 Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, achillion, hepatitis C, pharma

Johnson & Johnson has announced that it is to back out of a $1.1 billion deal with Achillion Pharmaceuticals to …
News

Teva announces sale of Paragard for $1.1 billion

September 12, 2017 Manufacturing and Production, Sales and Marketing Paragard, Teva, biotech, drugs, pharma, pharmaceutical

Shortly after the news that Teva had finally sealed the deal on a new CEO, it also announced that it …
News

FDA accepts license application for Novartis’ rituximab biosimilar

September 12, 2017 Manufacturing and Production, Sales and Marketing Novartis, Rituxan, Sandoz, biosimilar, rituximab

Sandoz, Novartis’ generics and biosimilars division, has revealed that the FDA has accepted its Biologics License Application (BLA) for a …
News

Questions raised after two deaths in AbbVie arthritis study

September 12, 2017 Manufacturing and Production, Research and Development AbbVie, biotech, drugs, pharma, pharmaceutical, rheumatoid arthritis

AbbVie’s rheumatoid arthritis drug, upadacitinib, is the company’s big plan to manage the inevitable loss of sales from Humira, as …
News
new_brand_image_sept_2017

PrimeVigilance launches new brand and logo

September 12, 2017 Manufacturing and Production, Sales and Marketing pharmacovigilance, primevigilance

PrimeVigilance has launched its new visual identity together with a new website. Additionally, it has begun harmonising its appearance within …
News
ian_w

Ipsen announces new Vice President of Corporate External Communications

September 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen

French biopharmaceutical group Ipsen has announced that Dr Ian Weatherhead has taken up the position of Vice President, Corporate External …
Appointment
alzheimers-749616_960_720

Alzheimer’s disease: Fighting back against a growing threat

September 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's UK, dementia, life sciences, pharma

September marks Alzheimer’s Awareness Month, a crucial calendar period as the global threat of the disease slowly grows. To mark …
Feature
casebia_logo1_rgb

Casebia Therapeutics bolsters leadership by bringing in two new faces

September 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, CRISPR Therapeutics, Casebia Therapeutics, biotech, drugs, pharma, pharmaceutical

Casebia therapeutics, a joint venture between Bayer and CRISPR Therapeutics, has moved to strengthen its leadership team by bringing in …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

This week saw a number of hard-hitting stories hit the headlines that are sure to have resonant consequences. Following the …
News

Lily announces massive staff cuts of 3,500 to “streamline business”

September 8, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing

In a drastic bid to “streamline business, invest in new medicines and drive”, Eli Lilly has announced major staff cuts …
News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026